Menopausal hormone therapy
Menopausal hormone therapy after breast cancer: a meta analysis and critical appraisal of the evidence
... are menopausal either at diagno- sis or as a result of premature therapy-induced menopause, and they frequently experience climacteric symptoms ...[1]. Menopausal hormone therapy (HT), ...
6
Menopausal hormone therapy: a systematic review of cost effectiveness evaluations
... Menopausal hormone therapy (MHT) is considered an ef- fective treatment for menopausal symptoms [1]. However, to assess whether MHT is cost-effective in any group, benefits for quality of life ...
15
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
... MHT: menopausal hormone therapy; MMHS: Mayo mammography health study; OFBCR: Ontario familial breast cancer registry; P int : P -value for interaction; SASBAC: Singapore and ...
12
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?
... Abbreviations: CI, Confidence Interval; HR, Hazard Ratio, adjusted for attained age, age at menopause (continuous), and potential confounding variables (birth cohort (1908-39, 1940-44, 1945-49, 1950-54, 1955-85), time ...
41
Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case control study
... of menopausal hormone therapy, including timing and type of hormones for each treatment epi- sode, was also requested and a colour chart displaying all preparations ever marketed in Sweden was ...
13
Prescribing menopausal hormone therapy: an evidence-based approach
... regarding menopausal hormone therapy (MHT) has been challenging for providers caring for menopausal ...symptomatic menopausal women who are under 60 years of age or within 10 years of ...
11
Does menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial
... [30, 49] and isometric [50]) have been described for the management of Achilles and patellar tendinopathy, there is little evidence on effective exercise therapy in the re- habilitation of GTPS [37]. There is ...
12
Differences in Menopausal Hormone Therapy Use among Women in Germany between 1998 and 2003
... taking hormone preparations? Women answering in the affirmative to both questions were defined as 'current MHT users'; if only question 1 was affirmed, women were defined as past MHT ...
11
Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial
... (tE2) therapy administered within 3 to 36 months after the onset of menopause in the Kronos Early Estrogen Prevention Study (KEEPS) 15 did not have an effect on biomarkers of atherosclerosis or cognitive function ...
11
The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case control study in the California Teachers Study cohort
... To our knowledge, no studies have investigated genetic variation in SLCO1B1 and breast cancer risk by hormone therapy use. SLCO1B1, also known as OATP- C or SLC21A6, is expressed in the liver and plays an ...
11
Role of Hormone Replacement Therapy in Young Women Suffering from Menopausal Symptoms of Cancer —A Concise Review
... on menopausal hormone therapy, HRT must be individualized and tailored according to the symptoms, personal history (age, time since meno- pause, risk of venous thromboembolism, stroke, ischemic heart ...
8
Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study
... previous menopausal hormone therapy ...of hormone therapy at base- line was ...stopped hormone therapy to join PEPI (that is, recent users), the mean duration since last ...
7
Alternative methods for the treatment of post-menopausal troubles
... cause menopausal symptoms which may result in a decreased quality of ...life. Hormone therapy (estrogen/progestogen combination products) is one, but temporally limited option due to increased health ...
9
Plasma VEGF as a Marker of Therapy in Breast Cancer Patients.
... Results: There was a significant (P<0.001) increase in plasma VEGF level in breast cancer patients (Mean± SD 136.22±9.95) compared with controls(61.88±6.19). Our study showed that increased plasma VEGF levels were ...
7
“Role of Aromatase and Anastrozole in Cancer Treatment” by Salam A. Mohammed, Firas Hassan, Anil K. Philip, Mays Abd-Allateef, Emad Yousif, Sultanate of Oman.
... estrogen hormone level within the tumor (ophorectomy, aromatase inhibitors), they will adjust estrogen receptors (SERMS [tamoxifen, toremifene]); or they will adjust the estrogen receptor (ER) with uncontaminated ...
6
Variability of bothersome menopausal symptoms over time – a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT)
... This is a cohort study based on yearly follow-up ques- tionnaires sent to control women of a trial comparing combined hormone therapy to either placebo or nothing (the control groups) [21]. Women were ...
5
Hormone therapy for breast cancer
... the hormone receptor positive breast ...hormonal therapy) offers more benefits than 5 years of ...hormonal therapy to start with in early stage of a hormone receptor positive breast cancer, it ...
7
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis
... stimulating hormone (FSH; Gonal- F) with highly purified urinary FSH (Metrodin HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm ...
12
Considerations Related to the Use of Recombinant Human Growth Hormone in Children
... for therapy, the paucity of data on the long- term response to therapy, and screening efforts to identify candidates for ...GH therapy is the desire to make children grow; but how much, over how long ...
10
“Ghrelin and Leptin Changes in Serum of Postmenopausal Osteoporotic Iraqi Women after Three Months Oral Estrogen Therapy” by Elaf Mahmood Shihab, Mustafa G. Alabbassi, Khudair Z. AL-Bedri, Inas Taha Ahmad, Iraq.
... Randomized single blind clinical trial was carried out in Rheumatology outpatient Department of Baghdad Teaching Hospital / Medical city complex, from January 10 th till June 12 th , 2016. The sample size was (50) ...
5